How secondary prevention is implemented in clinical practice in male patients with a two-year history of coronary artery disease

Kardiologia Polska

Volumn 56, Issue 3, 2002, Pages 281-285

  Skibińska, Elzbieta ^a   Musiał, Włodzimierz J ^a   Prokop, Jolanta ^a   Bachórzewska Gajewska, Hanna ^a   Kowalska, Irina ^a   Kinalska, Ida ^a  

^a Klinika Kardiologii   (Poland)

Author keywords

Cardiovascular risk factors; Invasive treatment; Ischaemic heart disease; Secondary prophylactics

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARBOHYDRATE METABOLISM; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; ENZYME INHIBITION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIC HEART DISEASE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROPHYLAXIS; RISK FACTOR; SECONDARY PREVENTION;

EID: 0036211339     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Coronary risk profiles in men with coronary artery: Effects of body composition, fat distribution, age and fitness
2. Effect of smoking cessation on mortality after myocardial infarction: Meta-analysis of cohort studies
3. Standardy postȩpowania w chorobach uldadu kra̧żenia
4. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
5. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
6. Profilaktyka choroby niedokrwiennej serca
7. Zasady postȩpowania w nadciśnieniu tȩtniczym. Stanowisko polskiego towarzystwa nadciśnienia tȩtniczego i polskiego towarzystwa kardiologicznego
8. Leczenie hiperlipidemii po rewasularyzacji wieńcowej: Obserwacja po 1 roku
9. Choroba niedokrwienna serca - Leki zalecane przy wypisie. Krakowski program wtómej prewencji choroby niedokrwiennej serca
10. Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease
11. Use aspirin, beta-blockers, and lipid lowering medications before recurrent myocardial infarction: Missed opportunities for prevention
12. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries
13. A collective failure of medical practice?
14. A British Cardiac Society of the potential for secondary prevention of coronary diseases - "ASPIRE"
15. A European Society of Cardiology survey of secondary prevention of coronary heart disease - "EUROASPIRE"
16. Zaburzenia metabolizmu wȩglowodanów u pacjentów z choroba̧ niedokrwienna̧ serca
17. Pravastatin and the development of diabetes mellitus. Evidence for a protective treatment effect in the west of Scotland Coronary Prevention Study
18. Diabetes and cardiovascular risk factors in the Framingham Study
19. ACC/AHA guidelines for the management of patients with acute myocardial infarction
20. Management of dyslipidemia in adults with diabetes
21. Comparative effects of low and high doses of angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure